|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients without Hashimoto thyroiditis (HT) had 9.8-fold higher chance of being GR in comparison with HT patients.
|
31579982 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Conversely, a protective role has also been described in other autoimmune diseases where humoral responses are detrimental such as myasthenia gravis (MG), Hashimoto's thyroiditis (HT), inflammatory bowel disease (IBD), and systemic lupus erythematosus (SLE).
|
31275302 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our objective was to determine the prognostic value of acoustic structure quantification (ASQ) to predict the outcome of patients with Hashimoto's thyroiditis (HT).
|
30989347 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Introduction Hashimoto's thyroiditis (HT) is a chronic autoimmune inflammatory disorder of the thyroid gland with a prevalence of 1%-4%.
|
31754586 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Rheumatic manifestations are common in patients with Hashimoto's thyroiditis (HT).
|
31621191 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hashimoto's thyroiditis (HT) is a common autoimmune thyroid disease.
|
31824415 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hashimoto's thyroiditis (HT) is associated with excess psychiatric in addition to reduced quality of life.
|
31065912 |
2019 |
|
Hashimoto Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Previous evidence suggested that lymphocytic thyroiditis (LT) was a variant of Hashimoto's thyroiditis (HT), thus the aim of the current study is to quantify structural changes in histological specimens taken from HT and LT patients.
|
30813976 |
2019 |
|
Hashimoto Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Multivariate analysis using a Cox proportional hazards regression model shows that total tumor diameter (TTD) is associated with significantly higher recurrence for BMPTMC with or without other risk factors (Hazard Ratio (HRO) = 9.86 [95%CI 5.35-18.20], <i>p</i> = 0.00; HRO = 2.32 [95%CI 1.12-4.85], <i>p</i> = 0.02; respectively), while Hashimoto thyroiditis (HT) is found to be protective against the recurrence (HRO = 0.51 [95%CI 0.33-0.79], <i>p</i> = 0.00; HRO = 0.47 [95%CI 0.25-0.89], <i>p</i> = 0.02; respectively).
|
31297091 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study explored whether circulating exosomes effectively participate in the inflammatory response in Hashimoto thyroiditis (HT).
|
31199456 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although thyroid dysfunction caused by Hashimoto's thyroiditis (HT) is believed to be related to implantation failure due to the underdevelopment of the receptive uterus, it is unknown whether HT itself, even in the euthyroid state, impairs embryo implantation associated with endometrial receptivity defects.
|
31729993 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
A further aim was to examine whether differences in the content of metals exist in regard to the thyroid diseases, such as benign tumor (BT), Hashimoto's thyroiditis (HT), multinodular goiter (MNG) and thyroid cancer (TC).
|
31365889 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Results:</b> Of the 270 patients, there were NTP (<i>n</i> = 193), Hashimoto thyroiditis (<i>n</i> = 24), non-Hashimoto lymphocytic thyroiditis (<i>n</i> = 51), Graves' disease (<i>n</i> = 1), and diffuse hyperplasia (<i>n</i> = 1).
|
31781043 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We assessed the ability of a high-throughput proton NMR metabolomic profile to distinguish disease type amongst of Graves' disease (n=87), Hashimoto's thyroiditis (n=17), toxic goiter (n=11), and autoimmune thyroiditis [i. e., subacute thyroiditis (n=4), postpartum thyroiditis (n=1)].
|
30791054 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The aim of the study is to investigate the usefulness of ultrasound combined with computed tomography (CT) for distinguishing between primary thyroid lymphoma (PTL) and Hashimoto's thyroiditis (HT).
|
31529457 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hashimoto's thyroiditis (HT), the most frequent autoimmune thyroid disorders (AITDs), is the leading cause of hypothyroidism in the iodine-sufficient areas of the world.
|
31812326 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, several studies have suggested that thyroid cancer coexists with autoimmune thyroid diseases like Hashimoto Thyroiditis (HT) and Graves disease (GD).
|
30616690 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Current knowledge of HT genetics is limited, and not a single genome-wide association study (GWAS) focusing exclusively on HT has been performed to date.
|
30284222 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Correlation was found between BRAFV600E mutation and several epidemiological features, including age, concomitant hypertension and Hashimoto thyroiditis (HT).
|
31252408 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Investigations on the mechanisms of vitamin D action and pathogenesis of Hashimoto's thyroiditis (HT) have revealed that vitamin D can reduce damages to thyroid cells caused by autoreactive immune cells.
|
30696977 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We aimed to investigate the differences between spectral Doppler and Superb Microvascular Imaging (SMI; Canon Medical Systems, Tokyo, Japan) findings in children with Hashimoto thyroiditis (HT) and Graves disease (GD) compared to healthy control participants.
|
31705696 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
This case demonstrates that COP may present in combination with Hashimoto's thyroiditis (HT) and may possibly even be caused by HT.
|
31807148 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyroid nodules in children, although less common than in adults, have a greater risk of malignancies, particularly in those cases associated with anamnestic, clinical and ultrasonographic risk factors.Among the factors, which have been found to be linked with an increased relative risk of TC in children, an important role seems to be possibly played by an underlying nodular Hashimoto's thyroiditis (HT) and by the serum levels of TSH.Aim of this Commentary was to specifically address this last point.According to the available pediatric literature on the relationships between these risk factors and phenotypical expression of TC in children, it is possible to conclude that: 1) It is not completely clarified if HT per se predisposes to malignancy or if it represents an incidental histologic finding in cases with TC or if it may be the result of an immune response against tumoral cells.
|
31387613 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The current state of knowledge related to diet in Hashimoto thyroiditis (HT) is far from satisfactory, as many HT subjects experience several disorders and report reduced quality of life.
|
31810194 |
2019 |
|
Hashimoto Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
A clinical diagnosis model include thyroid functions, thyroid antibodies and radioactive iodine uptake (RAIU) of patients with hyperthyroidism were established and as new evaluation indicators for the differentiation of the Graves' disease (GD) and Hashimoto's thyroiditis (HT).
|
30616573 |
2019 |